|
Volumn 62, Issue 24, 2013, Pages 2344-2345
|
Peptide receptor-targeted radionuclide therapy alters inflammation in atherosclerotic plaques
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DOTATATE GA 68;
DOTATATE LU 177;
RADIOISOTOPE;
SOMATOSTATIN RECEPTOR 2;
UNCLASSIFIED DRUG;
ADULT;
ATHEROSCLEROTIC PLAQUE;
CARDIOVASCULAR RISK;
COMPUTER ASSISTED EMISSION TOMOGRAPHY;
DRUG TARGETING;
DRUG UPTAKE;
FEMALE;
HUMAN;
HYPERCHOLESTEROLEMIA;
INFLAMMATION;
LETTER;
MAJOR CLINICAL STUDY;
MALE;
MIDDLE AGED;
MOLECULARLY TARGETED THERAPY;
NEUROENDOCRINE TUMOR;
PEPTIDE RECEPTOR TARGETED RADIONUCLIDE THERAPY;
PET-CT SCANNER;
PRIORITY JOURNAL;
FEMALE;
HUMANS;
HYPERCHOLESTEROLEMIA;
INFLAMMATION;
MALE;
MIDDLE AGED;
MULTIMODAL IMAGING;
NEUROENDOCRINE TUMORS;
ORGANOMETALLIC COMPOUNDS;
PLAQUE, ATHEROSCLEROTIC;
POSITRON-EMISSION TOMOGRAPHY;
RADIOPHARMACEUTICALS;
RADIOTHERAPY;
RECEPTORS, SOMATOSTATIN;
RETROSPECTIVE STUDIES;
TOMOGRAPHY, X-RAY COMPUTED;
|
EID: 84890014173
PISSN: 07351097
EISSN: 15583597
Source Type: Journal
DOI: 10.1016/j.jacc.2013.08.1624 Document Type: Letter |
Times cited : (38)
|
References (6)
|